CTG, a Cegeka company, has partnered with Hippocratic AI to bring safe, patient-focused generative AI agents to healthcare organizations across the United States. Combining CTG’s decades of expertise in optimizing clinical workflows with Hippocratic AI’s patented Polaris Safety Constellation Architecture, the partnership aims to help hospitals and health systems improve care coordination, outreach, and patient engagement. Hippocratic AI’s clinically validated AI agents—tested through more than 7,000 clinicians and 500,000 test calls—are designed to extend the capacity of care teams, automate routine tasks, and safely interact with patients in multiple languages. The collaboration supports a broad range of use cases, including readmission reduction, health equity, and preventive care campaigns.
Together, CTG and Hippocratic AI are also developing a next-generation AI agent that transforms routine patient support, such as password resets and portal access issues, into opportunities for clinical engagement. By embedding intelligence into everyday interactions, the system can automatically help patients schedule follow-ups or close care gaps in real time. Leaders from both companies emphasized that the initiative reflects their shared commitment to improving access, reducing administrative burden, and maintaining the highest standards of patient safety. Hippocratic AI, backed by major investors including a16z, General Catalyst, and NVIDIA’s NVentures, continues to focus on building non-diagnostic, patient-facing AI agents that enhance healthcare delivery worldwide.